MwanzoONC • TSE
Oncolytics Biotech Inc
$ 1.20
27 Sep, 17:40:00 GMT -4 · CAD · TSE · Kanusho
HisaHisa zinazouzwa CAMakao yake makuu ni CA
Bei iliyotangulia
$ 1.22
Bei za siku
$ 1.20 - $ 1.22
Bei za mwaka
$ 1.20 - $ 3.03
Thamani ya kampuni katika soko
92.45M CAD
Wastani wa hisa zilizouzwa
elfu 45.11
Uwiano wa bei na mapato
-
Mgao wa faida
-
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(CAD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato
——
Matumizi ya uendeshaji wa biashara
7.92M10.61%
Mapato halisi
-7.26M2.49%
Kiwango cha faida halisi
——
Mapato kwa kila hisa
-0.1013.68%
EBITDA
-7.89M-10.55%
Asilimia ya kodi ya mapato
-1.33%—
Jumla ya mali
Jumla ya dhima
(CAD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Uwekezaji wa pesa taslimu na vipindi vifupi
24.85M2.05%
Jumla ya mali
32.07M0.32%
Jumla ya dhima
13.76M41.44%
Jumla ya hisa
18.31M—
hisa zilizosalia
76.99M—
Uwiano wa bei na thamani
5.08—
Faida inayotokana na mali
-59.26%—
Faida inayotokana mtaji
-90.99%—
Mabadiliko halisi ya pesa taslimu
(CAD)Jun 2024Mabadiliko Tangu Mwaka Uliopita
Mapato halisi
-7.26M2.49%
Pesa kutokana na shughuli
-6.82M19.44%
Pesa kutokana na uwekezaji
elfu -155.00-102.28%
Pesa kutokana na ufadhili
1.98M-46.51%
Mabadiliko halisi ya pesa taslimu
-4.75M-388.41%
Mtiririko huru wa pesa
-4.52M24.11%
Kuhusu
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Ilianzishwa
1998
Wafanyakazi
29
Tafuta
Futa utafutaji
Funga kisanduku cha kutafutia
Programu za Google
Menyu kuu